1
|
Danese S, Levesque BG, Feagan BG, Jucov A, Bhandari BR, Pai RK, Meadows KT, Kirby BJ, Bruey JM, Olson A, Osterhout R, Van Biene C, Ford J, Aranda R, Raghupathi K, Sandborn WJ. Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply. Aliment Pharmacol Ther 2022; 55:735-736. [PMID: 35245951 DOI: 10.1111/apt.16795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Affiliation(s)
- Silvio Danese
- IRCCS Ospedale San Raffaele and University Vita-Salute, San Raffaele, Milan, Italy
| | | | | | - Alina Jucov
- ARENSIA Exploratory Medicine GmbH, Düsseldorf, Germany
| | - B R Bhandari
- Nicolae Testemitanu State University of Medicine and Pharmacy, Chișinău, Moldova.,Delta Research Partners, Bastrop, Los Angeles, USA
| | | | | | | | | | - Allan Olson
- Gossamer, Bio, Inc., San Diego, California, USA
| | | | | | - Julia Ford
- Gossamer, Bio, Inc., San Diego, California, USA
| | | | | | | |
Collapse
|